The farnesoid X receptor: a potential target for expanding the therapeutic arsenal against kidney disease
Author:
Affiliation:
1. First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Funder
paper was not funded
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728222.2019.1559825
Reference98 articles.
1. Identification of a nuclear receptor that is activated by farnesol metabolites
2. Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
3. Identification of Gene-selective Modulators of the Bile Acid Receptor FXR
4. Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of Bile Acid Receptors in the Development and Function of Diabetic Nephropathy;Kidney International Reports;2024-08
2. Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease;Bioorganic Chemistry;2024-02
3. Farnesoid X receptor activation protects against renal fibrosis via modulation of β-catenin signaling;Molecular Metabolism;2024-01
4. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023;Pharmacological Reviews;2023-08-16
5. The roles of gut microbiota and its metabolites in diabetic nephropathy;Frontiers in Microbiology;2023-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3